Publikationen von P Müller

Maksymenko, K.; Maurer, A.; Aghaallaei, N.; Barry, C.; Borbarán-Bravo, N.; Ullrich, T.; Dijkstra, T.; Hernandez-Alvarez, B.; Müller, P.; Lupas, A. et al.; Skokowa, J.; ElGamacy, M.: The design of functional proteins using tensorized energy calculations. Cell Reports Methods 3 (8), 100560 (2023)

Skokowa, J.; Hernandez Alvarez, B.; Coles, M.; Ritter, M.; Nasri, M.; Haaf, J.; Aghaallaei, N.; Xu, Y.; Mir, P.; Krahl, A.-C. et al.; Rogers, K.; Maksymenko, K.; Bajoghli, B.; Welte, K.; Lupas, A.; Müller, P.; ElGamacy, M.: A topological refactoring design strategy yields highly stable granulopoietic proteins. Nature Communications 13 (1), 2948 (2022)

Hernandez Alvarez, B.; Skokowa, J.; Coles, M.; Mir, P.; Nasri, M.; Weidmann, L.; Rogers, K.; Welte, K.; Lupas, A.; Müller, P. et al.; ElGamacy, M.: Design of novel granulopoietic proteins by topological rescaffolding. PLoS Biology 18 (12), e3000919 (2020)

Böffert, R.; Businger, R.; Preiß, H.; Ehmann, D.; Truffault, V.; Simon, C.; Ruetalo, N.; Hamprecht, K.; Müller, P.; Wehkamp, J. et al.; Schindler, M.: The human α-defensin-derived peptide HD5(1-9) inhibits cellular attachment and entry of human cytomegalovirus. Antiviral Research 177, 104779 (2020)

Morishima, T.; Krahl, A.-C.; Nasri, M.; Xu, Y.; Aghaallaei, N.; Findik, B.; Klimiankou, M.; Ritter, M.; Hartmann, M.; Gloeckner, C. et al.; Stefanczyk, S.; Lindner, C.; Oswald, B.; Bernhard, R.; Hähnel, K.; Hermanutz-Klein, U.; Ebinger, M.; Handgretinger, R.; Casadei, N.; Welte, K.; Andre, M.; Müller, P.; Bajoghli, B.; Skokowa, J.: LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis. Blood 134 (14), S. 1159 - 1175 (2019)

Müller, P.; Nüsslein-Volhard, C.: Obituary: Hans Meinhardt (1938-2016). Development 143 (8), S. 1231 - 1233 (2016)

Maksymenko, K.; Hernandez Alvarez, B.; Ullrich, T.; Müller, P.; Skokowa, J.; Lupas, A.; ElGamacy, M.: Damietta: A Tensorised Protein Design Engine, and Its Application in Therapeutic Protein Design. In Advances in Protein Folding, Evolution and Design (APFED 2022), S. 67. Advances in Protein Folding, Evolution and Design (APFED 2022), Bayreuth, Germany, 06. April 2022 - 08. April 2022. (2022)

Maksymenko, K.; Müller, P.; Skokowa, J.; Lupas, A.; ElGamacy, M.: Protein design of growth factor inhibitors. In Advances in Protein Folding, Evolution and Design (APFED 2022), S. 29. Advances in Protein Folding, Evolution and Design (APFED 2022) , Bayreuth, Germany, 06. April 2022 - 08. April 2022. (2022)

Maksymenko, K.; Skokowa, J.; Lupas, A.; Müller, P.; ElGamacy, M.: De novo Protein Design of Vascular Endothelial Growth Factor Inhibitors. In Protein Science, 30 (Supplement 1), 140, S. 61. 35th Anniversary Symposium of The Protein Society, 07. Juli 2021 - 14. Juli 2021. Wiley, Hoboken, New Jersey, Vereinigte Staaten (2021)

Rogers, K.; ElGamacy, M.; Jordan, B.; Müller, P.: Investigating responses to BMP signaling with in vivo optogenetics. In 80th Annual Meeting of the Society for Developmental Biology (SDB 2021), 22, S. 11. 80th Annual Meeting of the Society for Developmental Biology (SDB 2021), 12. Juli 2021 - 16. Juli 2021. (2021)

Ullrich, T.; Pollmann, C.; Ritter, M.; Haaf, J.; Aghaallae, N.; Tesakov, I.; El-Riz, M.; Maksymenko, K.; Hatskovska, V.; Kandabarau, S. et al.; Klimiankou, M.; Lengerke, C.; Welte, K.; Hernandez-Alvarez, B.; Müller, P.; Lupas, A.; Piehler, J.; Skokowa, J.; ElGamacy, M.: Tuning of granulopoietic signaling by de novo designed agonists. (eingereicht)